However, in MCF-7 (moderate Trop2 expression) xenograft model, hIMB1636-LDP-AE displayed significantly more potent tumor inhibition effects than SG (hIMB1636-LDP-AE vs. SG P = 0.027, Fig. 8b), indicating that hIMB1636-LDP-AE might have better therapeutic effects against tumors with moderate Trop2 expression. Here, TACSTD2 is linked to neoplasm.